The role of CDK4/6 inhibitors in older and younger patients with breast cancer: A systematic review and meta-analysis
Breast, The, Volume 71, 2023 Oct, Pages 138-142 | Petrelli, Fausto; Dottorini, Lorenzo; Di Menna, Giandomenico;…AbstractIntroductionCyclin-dependent kinase 4/6 (CDK4/6) inhibitors have an extremely important impact on the treatment of hormone-sensitive breast cancer (BC) and have radically changed the first-line treatment for metastatic disease with increas…
Go to Source
This article was first shared by INDoximity